tiprankstipranks
Advertisement
Advertisement
COSCIENS Biopharma Addresses Unusual Trading Surge Amid Ongoing Risk Pressures
PremiumCompany AnnouncementsCOSCIENS Biopharma Addresses Unusual Trading Surge Amid Ongoing Risk Pressures
1M ago
COSCIENS Biopharma Slashes Losses, Shuts German Units as It Tightens Focus on Core Ingredients
Premium
Company Announcements
COSCIENS Biopharma Slashes Losses, Shuts German Units as It Tightens Focus on Core Ingredients
2M ago
COSCIENS Biopharma Shuts Off Funding to German Units, Exits Macrilen Business
Premium
Company Announcements
COSCIENS Biopharma Shuts Off Funding to German Units, Exits Macrilen Business
3M ago
COSCIENS Biopharma Reports Q3 2025 Results and Strategic Updates
PremiumCompany AnnouncementsCOSCIENS Biopharma Reports Q3 2025 Results and Strategic Updates
6M ago
COSCIENS Biopharma Reports Q2 2025 Results and Strategic Updates
Premium
Company Announcements
COSCIENS Biopharma Reports Q2 2025 Results and Strategic Updates
9M ago
COSCIENS Biopharma Reports Q2 2025 Results and Strategic Delisting from Nasdaq
Premium
Company Announcements
COSCIENS Biopharma Reports Q2 2025 Results and Strategic Delisting from Nasdaq
9M ago
COSCIENS Biopharma Schedules Virtual Annual Meeting for June 30, 2025
PremiumCompany AnnouncementsCOSCIENS Biopharma Schedules Virtual Annual Meeting for June 30, 2025
12M ago
COSCIENS Biopharma Receives Director Nominations Ahead of Shareholder Meeting
Premium
Company Announcements
COSCIENS Biopharma Receives Director Nominations Ahead of Shareholder Meeting
12M ago
Cosciens Biopharma announces receipt of Goodwood intended director nominations
Premium
The Fly
Cosciens Biopharma announces receipt of Goodwood intended director nominations
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100